Aveanna Healthcare Holdings Inc Reports Second Quarter 2024 Financial Results
Intellectia.AI1970-01-01
Aveanna Healthcare Holdings Inc. Reports Second Quarter 2024 Financial Results
Aveanna Healthcare Holdings Inc. has announced its financial results for the quarter ended June 29, 2024.
Key Financial Metrics:
| Metric | Q2 2023 | Q1 2024 | Q2 2024 | YoY Change (%) | QoQ Change (%) | Consensus Estimates |
|---|---|---|---|---|---|---|
| Total Revenue | $471.9M | $490.6M | $505.0M | +7.0% | +2.9% | $493.36M |
| Earnings Per Share (EPS) | $0.13 | $0.01 | $0.07 | -46.2% | +600.0% | -$0.02 |
Professional Interpretation: Aveanna Healthcare Holdings Inc. showed a solid performance in Q2 2024 with a 7.0% year-over-year increase in total revenue, beating the consensus estimate of $493.36 million. The company's earnings per share of $0.07 far exceeded the consensus estimate of -$0.02, marking a significant improvement from the previous quarter’s EPS of $0.01.
Revenue Performance by Segment:
| Segment | Q2 2023 Revenue | Q2 2024 Revenue | YoY Change (%) |
|---|---|---|---|
| Private Duty Services (PDS) | $376.1M | $406.3M | +8.0% |
| Home Health & Hospice (HHH) | $58.3M | $57.5M | -1.4% |
| Medical Solutions (MS) | $37.5M | $41.1M | +9.3% |
Professional Interpretation: The Private Duty Services segment led revenue growth with an impressive year-over-year increase of 8.0%, driven by both a 4.8% increase in volume and a 3.2% increase in revenue rate. Medical Solutions also posted a strong performance with a 9.3% revenue growth, largely attributed to a 10.6% increase in volume. However, the Home Health & Hospice segment saw a slight decline of 1.4% in revenue, reflecting a decrease in volume.
Stock Price Movement:
Following the earnings release, Aveanna’s stock price experienced a decline of approximately 3.35%.
Summary
Aveanna Healthcare Holdings Inc. demonstrated robust revenue growth in Q2 2024, particularly in its Private Duty Services and Medical Solutions segments. The company successfully exceeded consensus estimates both in revenue and earnings per share. However, the slight decline in the Home Health & Hospice segment and the lack of forward guidance or comments from the company's officers may have contributed to the post-earnings release stock price decline.
The report has been organized into a clear and concise format, with unnecessary sections removed.
Genasys Inc Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Toll Brothers Reports Fourth Quarter and Full Year 2024 Financial Results
OilDri Corporation of America Reports Record First Quarter Fiscal 2025 Results
Share